IP Verse

Margaret Dixon Limited opposition analysis

COMPANY ANALYSIS

Latest oppositions filed by Margaret Dixon Limited

Patent Number:
EP3334747
Title:
Charged Depth Filtration Of Antigen-Binding Proteins
Applicant:
AMGEN INC.
Opposition Date:
Jun 7, 2024
Patent Number:
EP3463315
Title:
Compositions And Methods Of Using Nintedanib For Treating Ocular Diseases With Abnormal Neovascularization
Applicant:
ADS THERAPEUTICS LLC
Opposition Date:
Mar 13, 2024
Patent Number:
EP3619232
Title:
Multikinase Inhibitors And Uses In Ocular Fibrosis
Applicant:
AIVIVA BIOPHARMA, INC.
Opposition Date:
Mar 4, 2024
Patent Number:
EP4010082
Title:
Multispecific Anti-Tcr Delta Variable 1 Antibodies
Applicant:
GAMMADELTA THERAPEUTICS LIMITED
Opposition Date:
Oct 25, 2023
Patent Number:
EP3119423
Title:
Treatment Of Cancer Using Chimeric Antigen Receptor
Applicant:
NOVARTIS AG
Opposition Date:
Sep 14, 2023
Patent Number:
EP3555064
Title:
Glp-1 Receptor Agonists And Uses Thereof
Applicant:
PFIZER INC.
Opposition Date:
Aug 23, 2023
Patent Number:
EP4005592
Title:
Virion-Like Delivery Particles For Self-Replicating Rna Molecules
Applicant:
GLAXOSMITHKLINE BIOLOGICALS S.A.
Opposition Date:
Jul 12, 2023
Patent Number:
EP2611467
Title:
Small Liposomes For Delivery Of Immunogen-Encoding Rna
Applicant:
GLAXOSMITHKLINE BIOLOGICALS SA
Opposition Date:
Apr 20, 2023
Patent Number:
EP3970742
Title:
Pegylated Liposomes For Delivery Of Immunogen-Encoding Rna
Applicant:
GLAXOSMITHKLINE BIOLOGICALS S.A.
Opposition Date:
Feb 24, 2023
Patent Number:
EP3981427
Title:
Pegylated Liposomes For Delivery Of Immunogen-Encoding Rna
Applicant:
GLAXOSMITHKLINE BIOLOGICALS S.A.
Opposition Date:
Feb 24, 2023

Competitors of Margaret Dixon Limited

NOVARTIS AG

GLAXOSMITHKLINE BIOLOGICALS SA

GLAXOSMITHKLINE BIOLOGICALS S.A.

Want to track Margaret Dixon Limited?

Feel free to send us a message here and we will get back to you